Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-03 Sale | 2023-05-05 5:03 pm | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 13,698 | $36.5 | $499,977 | 799,685 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-09 Disposition | 2023-08-09 4:25 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 1,834,811 | $0 | 0 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:30 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 6:52 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 384,900 | $0 | 384,900 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 9:18 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 300,226 | $0 | 1,113,609 (Direct) | View |
Ownership | 2021-09-14 7:01 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 0 | $0 | 971,644 (Direct) | View |